BP
MRNA icon

BNP Paribas’s Moderna MRNA Stock Holding History

BNP Paribas’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$150K Sell
2,950
-850
-22% -$39.7K ﹤0.01% 232
2025
Q4 		$112K Hold
3,800
– – ﹤0.01% 257
2025
Q3 		$98.2K Hold
3,800
– – ﹤0.01% 241
2025
Q2 		$105K Hold
3,800
– – ﹤0.01% 246
2025
Q1 		$108K Buy
3,800
+3,200
+533% +$114K ﹤0.01% 244
2024
Q4 		$24.9K Buy
600
+215
+56% +$10.3K ﹤0.01% 306
2024
Q3 		$25.7K Sell
385
-532
-58% -$48.8K ﹤0.01% 291
2024
Q2 		$110K Sell
917
-100
-10% -$12.7K 0.01% 235
2024
Q1 		$109K Buy
+1,017
New +$103K 0.01% 244

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas's MRNA Position: Q1 2026 in Review

BNP Paribas reduced its Moderna (MRNA) stake by 22% in Q1 2026, selling an estimated $39.7K and leaving 2,950 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #232.

BNP Paribas first reported a position in MRNA in Q1 2024 and has held it in 9 quarters since. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • BNP Paribas held 2,950 shares of Moderna worth $150K as of Q1 2026.
  • BNP Paribas sold 850 Moderna shares in Q1 2026, an estimated $39.7K.
  • Moderna made up ﹤0.01% of BNP Paribas's portfolio in Q1 2026, its #232 holding.
  • BNP Paribas first reported a position in Moderna in Q1 2024 and has held it in 9 quarters since.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.